Asaf Maoz

Pathogenic and likely pathogenic variants in <i>PALB2</i> , <i>CHEK2</i> , and other known breast cancer susceptibility genes among 1054 <i>BRCA</i> ‐negative Hispanics with breast cancer

Jeffrey N. Weitzel, Susan L. Neuhausen, Aaron W. Adamson et al. · Cancer · 2019 · 63 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis

Rebeca Sanz‐Pamplona, Marilena Melas, Asaf Maoz et al. · PLoS Medicine · 2020 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer

Koji Matsuo, Shinya Matsuzaki, David J. Nusbaum et al. · Gynecologic Oncology · 2020 · 32 citations

Medicine, Oncology, Surgery +15

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction

Kyle Vaccaro, Juliet Allen, Troy W. Whitfield et al. · Journal of Clinical Investigation · 2024 · 16 citations · Full text

Life Sciences, Immunology, Oncology +17

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

Vaia Florou, Charalampos S. Floudas, Asaf Maoz et al. · Journal for ImmunoTherapy of Cancer · 2023 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17